“…These cardiac complications in regularly transfused patients are a culmination of two factors: (i) the human body has a limited ability to excrete excess iron (Fassos et al , 1996; Hershko et al , 2005) and (ii) iron deposits in the heart are detectable when the liver and spleen iron stores are already full and are thus indicative of advanced disease (Johnston et al , 1989). The cardiovascular effects of the myocardial iron deposits are extensive and include endothelial dysfunction (Gaenzer et al , 2002), increased heart wall thickness (Aessopos et al , 2004), atherosclerosis (Meyers, 2000), valvular diseases (Farmakis et al , 2004; Wu et al , 2004), coronary artery disease (Sonakul et al , 1988; Mariotti et al , 1993; Hahalis et al , 2005), heart failure (Kremastinos et al , 2001; Schwartz et al , 2002; Hahalis et al , 2005), arrhythmias (Kucukosmanoglu et al , 2002; Borgna‐Pignatti et al , 2004) pulmonary artery hypertension (Aessopos et al , 2007) and disturbed lipid metabolism (Al‐Quobaili & Abou Asali, 2004; Chrysohoou et al , 2004).…”